mutat
rate
evolv
genet
drift
indirect
select
due
genet
hitchhik
direct
select
physicochem
cost
high
fidel
howev
mani
system
difficult
disentangl
rel
impact
forc
empir
rna
virus
observ
correl
mutat
rate
virul
led
mani
argu
extrem
high
mutat
rate
advantag
may
allow
increas
adapt
argument
profound
implic
suggest
pathogenesi
mani
viral
infect
depend
rare
de
novo
mutat
present
data
altern
model
wherebi
rna
virus
evolv
high
mutat
rate
byproduct
select
increas
replic
speed
find
polioviru
antimut
signific
replic
defect
wild
type
popul
similar
adapt
two
distinct
cellular
environ
experiment
evolut
rselect
led
revers
compens
fidel
phenotyp
mice
infect
exhibit
delay
morbid
dose
well
ld
consist
attenu
slower
growth
oppos
reduc
mutat
suppli
furthermor
compens
growth
defect
restor
virul
compens
fidel
phenotyp
data
consist
kinet
proofread
model
biosynthet
reaction
suggest
speed
import
accuraci
contrast
suggest
mani
rna
virus
find
within
host
spread
associ
viral
replic
speed
stand
genet
divers
mutat
rate
sinc
mutat
deleteri
mutat
rate
tune
natur
select
ask
nt
viru
evolv
lower
mutat
rate
use
experiment
evolut
murin
infect
model
show
rna
viru
mutat
rate
may
actual
high
necessarili
adapt
rather
data
indic
viral
mutat
rate
driven
higher
result
select
virus
faster
replic
kinet
suggest
virus
high
mutat
rate
facilit
adapt
hard
fast
accur
introduct
mutat
ultim
sourc
genet
variat
mutat
rate
signific
impact
evolutionari
rate
intraspecif
variabl
mutat
rate
mani
virus
bacteria
indic
mutat
rate
optim
natur
select
given
mutat
deleteri
burden
excess
mutat
load
select
strain
abnorm
high
mutat
rate
principl
led
sturtev
ask
mutat
rate
evolv
zero
larg
bodi
theoret
experiment
work
suggest
select
pressur
higher
mutat
rate
due
either
physicochem
cost
maintain
lower
one
select
advantag
increas
suppli
benefici
mutat
mani
argu
adapt
benefit
high
mutat
rate
pathogen
microb
often
exist
dynam
environ
subject
host
immun
pressur
howev
direct
select
variant
higher
mutat
rate
occur
advantag
past
mani
case
difficult
separ
caus
higher
mutat
rate
consequ
ccbi
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
rna
virus
ideal
system
studi
select
forc
act
mutat
rate
interspecif
mutat
rate
rang
error
per
nucleotid
copi
studi
antimut
hypermut
suggest
fidel
vari
sever
fold
within
speci
sever
burden
mutat
load
exert
strong
downward
pressur
mutat
rate
hypermut
strain
attenu
vivo
given
short
gener
time
remark
fecund
mani
rna
virus
small
kinet
cost
higher
fidel
result
strong
select
antimut
howev
observ
attenu
antimut
rna
virus
vivo
led
mani
argu
adapt
benefit
high
mutat
rate
genet
divers
provid
rich
substrat
viru
evolut
face
vari
intrahost
environ
concept
central
viral
quasispeci
theori
gener
propos
link
genet
divers
viral
fit
defin
select
forc
shape
viral
mutat
rate
studi
antimut
variant
mutant
polioviru
select
serial
passag
ribavirin
rna
viru
mutagen
rna
depend
rna
polymeras
rdrp
variant
contain
singl
glycin
serin
substitut
basal
mutat
rate
report
wild
type
viru
wt
mutant
attenu
polioviru
receptor
transgen
mice
rel
import
replic
speed
fidel
phenotyp
clear
biochem
assay
suggest
physicochem
cost
high
fidel
system
contribut
overal
fit
remain
unquantifi
result
measur
rel
fit
direct
competit
serial
passag
qpcr
fig
fit
replic
rel
wt
moder
fit
defect
fall
th
percentil
dataset
fit
valu
ccbi
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
obtain
point
mutant
polioviru
similar
condit
eg
hela
cell
moi
hour
infect
cycl
passag
fig
also
measur
rel
growth
properti
wt
use
plaqu
size
assay
measur
growth
burst
size
spread
individu
virus
absenc
competit
distribut
clonal
plaqu
size
significantli
differ
p
unpair
ttest
welch
correct
wt
plaqu
consist
moder
fit
defect
fig
contrast
prior
work
abl
detect
signific
replic
defect
one
step
growth
curv
rigor
synchron
frequent
time
point
larger
number
replic
fig
replic
defect
specif
hela
observ
similar
lag
cell
line
deriv
mous
embryon
fibroblast
polioviru
receptor
transgen
mice
fig
data
demonstr
fit
defect
larg
attribut
slower
replic
kinet
consist
biochem
assay
purifi
rdrp
reduc
mutat
rate
replic
fit
suggest
tradeoff
speed
fidel
rna
viru
replic
fit
gain
increas
replic
speed
offset
reduct
fit
due
increas
mutat
load
deriv
quantit
model
tradeoff
see
si
model
measur
replic
fit
fig
mutat
rate
fig
tabl
wt
exposur
exogen
mutagen
ribavirin
wild
type
equal
fit
approxim
ribavirin
base
data
model
indic
wt
incur
fit
cost
mutat
load
alon
therefor
fit
benefit
high
baselin
mutat
rate
wt
would
presum
need
offset
cost
cost
mutat
load
reduc
viral
rdrp
constrain
speedfidel
tradeoff
select
increas
replic
speed
rselect
increas
mutat
rate
subject
point
mutant
rselect
serial
passag
infect
cell
low
multipl
harvest
progeni
hour
midexponenti
phase
replic
point
mutant
revert
wt
within
passag
independ
lineag
fig
observ
partial
revers
passag
subset
control
lineag
viru
popul
underw
twice
mani
cellular
infect
cycl
per
passag
experienc
reduc
rselect
next
ask
whether
rselect
would
lead
genet
compens
fidel
phenotyp
three
posit
codon
mutat
minim
revers
passag
rselect
identifi
fix
polymorph
singl
nucleotid
variant
snv
next
gener
sequenc
rselect
control
hour
passag
popul
wt
fig
unbias
hierarch
cluster
snv
type
frequenc
indic
virus
explor
distinct
mutat
pathway
adapt
either
rselect
control
passag
regim
within
rselect
group
wt
lineag
cluster
togeth
note
larger
number
snv
within
code
region
rdrp
across
five
popul
surprisingli
found
number
distinct
snv
increas
viral
fit
introduc
ancestr
wt
backbon
exampl
fit
presenc
rselect
control
lineag
suggest
mediat
adapt
hela
cell
contrast
mutat
viral
helicas
found
rselect
popul
fit
wt
would
like
gener
effect
replic
speed
identifi
compensatori
mutat
focus
subsequ
analysi
nonsynonym
mutat
rdrp
found
predominantli
rselect
popul
share
among
multipl
lineag
frequent
wt
two
mutat
mutat
may
arisen
first
mutat
found
rselect
wt
lineag
chang
either
fit
mutat
rate
appreci
background
fig
rselect
substitut
found
lineag
wt
popul
decreas
overal
fit
wt
vs
wt
ttest
vs
ttest
detect
effect
mutat
rate
either
background
tripl
mutant
signific
increas
fit
vs
ttest
mutat
rate
x
snr
vs
ttest
compar
doubl
mutant
therefor
direct
select
replic
speed
caus
increas
polioviru
mutat
rate
sign
epistasi
among
rdrp
gain
mechanist
insight
interact
among
three
mutat
analyz
kinet
singlebas
incorpor
misincorpor
purifi
rdrp
rdrp
exhibit
assembl
defect
rel
incub
purifi
templat
atp
fig
mutat
partial
compens
adapt
wt
high
fidel
virus
gener
compar
use
assay
measur
acquisit
drug
resist
revers
attenu
point
mutat
escap
microrna
limit
number
replic
cycl
experi
mutat
come
littl
cost
assay
essenti
quantifi
benefici
mutat
rate
captur
better
impact
deleteri
benefici
mutat
adapt
measur
fit
gain
wt
twenti
passag
hela
wt
strain
cultureadapt
found
far
fit
peak
wt
increas
fit
tenfold
approxim
cellular
infect
cycl
passag
fig
fig
differ
rate
fit
gain
wt
lineag
small
statist
signific
per
passag
wt
mix
linear
effect
model
examin
adapt
complet
distinct
environ
repeat
experi
cell
line
altern
speci
cell
type
actual
observ
greater
fit
gain
high
fidel
variant
rel
wt
per
passag
mix
linear
effect
model
larger
fit
gain
cell
may
reflect
larger
suppli
benefici
compensatori
mutat
given
lower
baselin
fit
cell
data
suggest
despit
twofold
reduct
mutat
rate
mutat
limit
adapt
benefit
higher
mutat
rate
counter
fit
cost
increas
mutat
load
see
fig
associ
model
next
compar
phenotyp
wt
virus
vivo
abil
gener
genet
divers
may
allow
viru
escap
host
immun
restrict
replic
better
rang
environ
importantli
avail
data
suggest
attenu
high
fidel
variant
experiment
model
attribut
differ
genet
divers
infect
popul
therefor
use
next
gener
sequenc
compar
genet
divers
replic
stock
wt
use
intern
benchmark
analysi
pipelin
dramat
reduc
fals
posit
variant
call
see
method
identifi
variant
greater
frequenc
therefor
exclud
signific
differ
stand
genet
divers
wt
popul
even
extrem
high
multipl
infect
variant
present
unlik
complement
cooper
reproduc
cellular
context
vivo
absenc
mutat
divers
replic
wt
stock
import
polioviru
popul
subject
stringent
bottleneck
event
restrict
intrahost
divers
work
barcod
rna
virus
suggest
serial
bottleneck
infect
popul
termin
popul
colon
central
nervou
system
cn
quit
stringent
use
publish
data
quantifi
aggreg
bottleneck
size
encount
polioviru
transgen
mice
maximum
likelihood
optim
simpl
probabilist
model
estim
aggreg
bottleneck
size
inoculum
cn
fig
si
model
therefor
popul
caus
eventu
diseas
mice
deriv
virus
infect
popul
set
tight
bottleneck
mani
mutat
increas
frequenc
due
genet
drift
oppos
posit
select
infect
group
pvr
mice
intramuscularli
wt
popul
virus
abl
access
cn
effici
rout
rang
dose
fig
tabl
clear
delay
group
p
p
pfu
inocula
respect
lag
persist
even
increas
number
rare
undetect
variant
inoculum
infect
dose
higher
ld
tabl
virus
spread
cn
replic
high
titer
intraven
inocul
although
wt
titer
brain
spinal
cord
margin
higher
day
post
infect
figur
brain
spinal
cord
mann
whitney
u
test
wt
mice
gener
develop
sever
morbid
rapidli
infect
character
mutat
present
cn
popul
rare
none
share
among
mice
excess
synonym
noncod
variant
rel
nonsynonym
one
data
consist
random
sampl
infect
popul
oppos
posit
select
also
examin
impact
rselect
mutat
virul
mutat
confer
fit
background
appear
affect
fidel
fig
restor
virul
nearli
wt
level
log
rank
test
compar
fig
contrast
tripl
mutant
replic
wild
type
mutat
rate
margin
increas
fit
slightli
virul
high
fidel
variant
log
rank
test
compar
fig
therefor
restor
replic
speed
restor
virul
compens
fidel
phenotyp
use
wellstudi
antimut
variant
polioviru
identifi
select
forc
optim
pathogen
mutat
rate
use
three
differ
assay
identifi
signific
fit
cost
higher
fidel
directli
link
cost
viral
replic
kinet
quantit
model
speedfidel
tradeoff
suggest
select
replic
speed
push
viral
mutat
rate
level
impos
signific
fit
cost
baselin
due
lethal
highli
deleteri
mutat
consist
tradeoff
model
direct
select
increas
replic
speed
led
indirect
select
polymeras
higher
mutat
rate
genet
interact
quit
strong
two
compensatori
mutat
exhibit
reciproc
sign
epistasi
speedfidel
tradeoff
polioviru
rdrp
appear
generaliz
phenomenon
compensatori
mutat
increas
replic
speed
antimut
also
increas
mutat
rate
tabl
given
structur
similar
among
viral
rdrp
polymeras
rna
virus
like
subject
speedfidel
tradeoff
predict
molecular
mechan
govern
polymeras
kinet
mutat
rate
similar
tradeoff
essenti
constraint
forc
one
paramet
chang
anoth
case
viral
mutat
rate
chang
replic
speed
similar
tradeoff
central
kinet
proofread
hypothesi
posit
close
relationship
error
rate
biosynthet
process
kinet
compon
reaction
interestingli
studi
dna
replic
protein
translat
suggest
system
optim
speed
accuraci
long
error
rate
within
toler
rang
find
similar
phenomenon
viral
rdrp
wt
gener
extraordinari
amount
mutat
load
larg
benefit
replic
speed
failur
consid
evolutionari
tradeoff
lead
teleolog
error
consequ
process
eg
increas
genet
divers
misinterpret
caus
eg
direct
select
higher
mutat
rate
similarli
find
wide
accept
link
within
host
genet
divers
virul
confound
fact
faster
replic
virus
virul
higher
mutat
rate
high
mutat
rate
rna
virus
highli
deleteri
fit
effect
mutat
ensur
genet
divers
extrem
rare
unlik
consist
maintain
face
intrahost
interhost
bottleneck
disput
viru
popul
harbor
minor
variant
subset
mutat
may
adapt
benefici
viru
may
virul
determin
howev
observ
genet
divers
evid
select
optim
mutat
rate
futur
benefit
novel
mutat
inde
data
show
littl
adapt
benefit
margin
increas
mutat
rate
identifi
plausibl
mechan
wherebi
observ
increas
rare
genet
divers
influenc
pathogenesi
suspect
rna
virus
subject
off
evolutionari
signific
perhap
polymeras
speed
recombin
rate
recombin
rate
polymeras
fidel
import
defin
select
forc
play
therebi
separ
caus
consequ
presenc
desir
mutat
absenc
addit
mutat
verifi
sanger
sequenc
amplifi
insert
case
entir
genom
vitro
transcript
transfect
viral
stock
viral
rna
gener
vitro
transcript
correspond
plasmid
clone
use
rna
polymeras
viru
recov
follow
rna
transfect
hela
transfect
x
hela
plate
per
well
well
plate
day
prior
one
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
stock
cell
subject
three
freezethaw
cycl
supernat
clarifi
centrifug
x
g
minut
supernat
store
minu
aliquot
limit
number
subsequ
freezethaw
cycl
competit
assay
viral
fit
competit
assay
perform
essenti
describ
experi
three
replic
well
infect
pair
virus
one
hour
occasion
rock
one
hour
inoculum
remov
fresh
media
appli
passag
viru
harvest
addit
hour
hour
sinc
infect
titer
passag
viru
use
calcul
dilut
factor
necessari
maintain
moi
subsequ
passag
rna
harvest
passag
use
trizol
ambion
random
hexam
use
prime
cdna
synthesi
rna
cdna
analyz
real
time
pcr
use
three
differ
primer
andor
probe
set
duplic
pcr
reaction
sampleprim
set
first
set
catggcagccccggaacagg
tgtgatggatccgggggtagcg
use
quantifi
total
viral
genom
rna
sybr
green
reaction
power
sybr
green
pcr
master
mix
thermo
two
custom
taqman
probe
appli
biosystem
use
quantifi
number
wt
genom
duplic
well
averag
rel
amount
wt
rna
determin
normal
cycl
threshold
probe
com
primer
set
ct
viru
ct
com
normal
valu
viru
passag
compar
passag
obtain
ratio
rel
px
rel
ct
valu
convert
reflect
fold
chang
ratio
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
perform
exact
manner
except
serum
free
media
use
drug
mock
passag
competit
assay
fig
compar
experiment
viru
eg
wt
etc
tag
wt
refer
plate
x
cell
per
well
either
hela
pvr
well
plate
infect
perform
moi
complet
media
hour
hour
media
aspir
fresh
growth
media
appli
passag
hour
dilut
factor
passag
requir
maintain
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
singl
replic
cycl
growth
curv
day
prior
infect
x
hela
cell
plate
well
plate
well
per
viru
time
point
replic
per
time
point
cell
infect
moi
volum
incub
ice
hour
occasion
rock
one
hour
inocula
aspir
well
wash
twice
ice
cold
pb
fresh
prewarm
growth
media
appli
well
one
set
well
immedi
frozen
time
point
plate
return
incub
set
well
remov
frozen
hour
sampl
titer
tcid
growth
curv
cell
perform
use
similar
protocol
except
x
cell
plate
day
prior
time
point
hour
lyse
cell
media
harvest
follow
three
complet
freezethaw
cycl
transfer
microcentrifug
tube
empti
well
rins
complet
growth
media
combin
initi
lysat
lysat
clarifi
centrifug
x
g
minut
twentyfour
well
titer
plaqu
assay
ccbi
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
guanidin
hydrochlorid
overlay
see
p
five
well
titer
standard
plaqu
assay
without
guanidin
hydrochlorid
see
n
f
mutat
rate
estim
data
use
p
nullclass
model
lnp
n
f
n
p
fraction
cultur
yield
guanidin
resist
plaqu
n
f
averag
number
pfu
absenc
guanidin
n
averag
number
pfu
inoculum
although
total
among
plaqu
tabl
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
moi
x
tcid
unit
media
one
hour
occasion
rock
one
hour
inoculum
aspir
cell
wash
twice
pb
fresh
growth
media
appli
first
passag
wt
virus
harvest
hour
respect
passag
wt
virus
harvest
hour
respect
control
popul
infect
manner
except
virus
harvest
hour
post
infect
rselect
wt
lineag
select
lineag
control
wt
lineag
control
lineag
virus
titer
everi
th
passag
maintain
moi
approxim
rdrp
slower
polymer
kinet
higher
fidel
rel
wt
rdrp
similar
characterist
see
tabl
hela
cell
transfect
electropor
viral
rna
transcript
ad
hela
cell
monolay
incub
two
day
media
passag
onto
separ
monolay
hela
cell
upon
cytopath
effect
virus
harvest
three
repeat
freezethaw
cycl
cell
debri
remov
centrifug
viral
supernat
titrat
time
frame
titer
increas
approxim
x
pfuml
x
viral
rna
isol
qiaamp
viral
rna
purif
kit
qiagen
accord
manufactur
instruct
cdna
prepar
purifi
viral
rna
rtpcr
sequenc
substitut
identifi
togeth
one
experi
substitut
identifi
second
see
tabl
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
verifi
dna
sequenc
pv
rdrp
express
purifi
describ
previous
symsub
assay
use
measur
assemblyelong
kinet
purifi
rdrp
defin
templat
perform
describ
assay
primertempl
enzym
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
bilater
hindlimb
paralysi
assess
perform
member
univers
veterinari
technic
staff
blind
hypothes
expect
outcom
studi
surviv
anim
euthan
day
endpoint
also
use
calcul
use
spearmankarb
method
tabl
tissu
distribut
analys
mice
infect
intraven
via
tail
vein
observ
twice
daili
mice
euthan
sever
morbid
day
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
min
hold
sampl
amplif
fragment
confirm
gel
electrophoresi
equal
quantiti
pcr
product
pool
seven
hundr
fifti
nanogram
cdna
mixtur
shear
averag
size
use
covari
focus
ultrason
sequenc
librari
prepar
use
nebnext
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
separ
rtpcr
reaction
sequenc
librari
sampl
copi
number
genom
per
exampl
tissu
studi
strategi
variant
call
well
benchmark
sensit
specif
describ
code
found
http
githubcomlauringlabvariantpipelin
statist
analysi
explicit
power
analys
use
design
experi
case
use
biolog
replic
case
use
fewer
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
figur
rselect
lead
increas
mutat
rate
point
mutant
ggtgli
agtser
introduc
polioviru
genom
mark
nearbi
point
mutat
ablat
acci
restrict
site
virus
serial
passag
everi
hour
rselect
everi
hour
control
passag
chromatogram
show
codon
posit
either
ggtgli
agtser
gel
imag
acci
restrict
digest
passag
popul
show
revers
occur
parent
backbon
due
contamin
wt
viru
retain
acci
site
b
wt
lock
version
ggtgli
ucas
subject
rselect
hour
hour
respect
control
hour
passag
passag
describ
text
heatmap
show
mutat
identifi
frequenc
total
lineag
color
log
frequenc
diagram
left
show
region
polioviru
genom
c
fit
indic
variant
rel
wt
determin
competit
assay
symbol
replic
competit
assay
exact
pvalu
key
comparison
provid
main
text
mutat
rate
indic
variant
mutat
per
nucleotid
per
strand
copi
determin
luria
delbruck
fluctuat
test
symbol
replic
fluctuat
test
exact
pvalu
key
comparison
provid
main
text
e
vitro
kinet
purifi
rdrp
purifi
rdrp
primertempl
atp
incub
sampl
quench
indic
time
point
schemat
kinet
complex
assembl
singlebas
incorpor
express
extend
templat
yaxi
time
xaxi
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
simul
repres
mice
mous
bottleneck
size
drawn
zerotrunc
poisson
averag
lambda
blue
magenta
line
actual
data
refer
shade
region
repres
area
occupi
simul
dark
shade
region
repres
interquartil
rang
simul
b
surviv
curv
show
mice
paralysi
free
surviv
time
group
per
viru
infect
intramuscularli
pfu
left
pfu
center
pfu
right
wt
black
dash
blue
p
p
log
rank
test
c
viral
titer
brain
spinal
cord
day
post
intraven
inocul
pfu
wt
fill
circl
open
circl
p
p
mann
whitney
u
test
mice
group
infect
one
mous
group
titer
limit
detect
dot
line
one
mous
group
titer
limit
detect
dot
line
histogram
frequenc
intrahost
snv
identifi
spinal
cord
mice
panel
infect
wt
infect
black
synonym
noncod
blue
nonsynonym
e
surviv
curv
show
mice
paralysi
free
surviv
time
group
per
viru
combin
two
experi
see
tabl
infect
intramuscularli
pfu
dash
blue
orang
p
log
rank
test
actual
p
valu
f
surviv
curv
show
mice
paralysi
free
surviv
time
group
per
viru
combin
two
experi
see
tabl
infect
intramuscularli
pfu
dash
blue
pink
p
log
rank
test
actual
p
valu
premis
speedfidel
tradeoff
outcom
competit
two
viral
strain
determin
two
oppos
forc
speed
genom
replic
error
rate
replic
faster
genom
replic
happen
error
occur
greater
mutat
load
scenario
optim
competit
fit
achiev
exactli
increas
fit
counterbalanc
decreas
fit
excess
mutat
load
present
simpl
mathemat
model
demonstr
tradeoff
fit
model
experiment
data
start
classic
estim
haldan
c
c
b
genom
replic
rate
u
u
b
deleteri
genom
mutat
rate
per
genom
per
gener
strain
b
respect
understand
effect
mutagen
rel
fit
one
strain
anoth
add
mutat
rate
multipli
mu
extern
multipl
modifi
baselin
mutat
rate
constrain
take
valu
greater
one
mutat
two
effect
see
also
fig
mutat
result
increas
fidel
repres
downward
shift
line
mutat
also
result
rel
resist
ribavirin
manifest
decreas
slope
need
includ
estim
mutat
load
experienc
wt
mutant
replic
presenc
increas
mutagen
linear
regress
fit
wt
mutat
rate
produc
good
fit
r
respect
highli
statist
signific
p
fit
linear
regress
use
estim
mutat
rate
wt
absenc
ribavirin
x
snr
snr
respect
point
equilibrium
solv
two
unknown
variabl
n
number
deleteri
site
genom
ii
c
fit
cost
mutat
absenc
mutat
load
rel
wild
type
arbitrarili
set
two
unknown
variabl
need
two
equat
solv
use
measur
rel
fit
absenc
ribavirin
ribavirin
concentr
rel
fit
expect
see
fig
use
mutat
rate
estim
strain
ribavirin
concentr
conc
ribavirin
fit
rel
wt
measur
give
us
first
equat
ccbi
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
develop
follow
model
measur
effect
bottleneck
restrict
polioviru
popul
site
inocul
central
nervou
system
appli
simpl
probabilist
model
data
describ
studi
mice
infect
x
pfu
polioviru
fold
higher
ld
particular
mous
model
inocula
consist
subpopul
equal
concentr
tag
neutral
sequenc
bar
code
separ
experi
author
show
bar
code
present
site
infect
four
bar
code
capabl
replic
simultan
brain
rare
bar
code
present
brain
follow
infect
suggest
popul
subject
within
host
bottleneck
similar
result
observ
iv
ip
rout
infect
fact
im
appear
least
stringent
mode
infect
estim
bottleneck
site
infect
brain
model
infect
process
random
sampl
event
assumpt
justifi
evid
jackpot
mutat
need
enter
central
nervou
system
ii
bar
code
select
neutral
iii
bar
code
equal
like
present
brain
probabl
sampl
size
contain
uniqu
type
given
total
uniqu
type
avail
present
equal
frequenc
deriv
discret
probabl
theori
given
term
experiment
design
interest
probabl
subset
size
contain
barcod
given
possibl
barcod
maximum
likelihood
optim
reveal
bottleneck
pfu
best
match
data
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
order
neglig
search
maxim
sum
log
likelihood
calcul
mous
found
confid
interv
best
fit
data
mean
truncat
poisson
given
therefor
mean
bottleneck
size
test
fit
perform
simul
simul
includ
mice
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
also
check
fit
ask
output
simul
match
actual
experiment
data
eg
often
see
mice
bar
code
contrast
replic
data
simul
bottleneck
ccbi
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
figur
ccbi
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
figur
vitro
assay
polymeras
mediat
singl
nucleotid
incorpor
schemat
gtp
misincorpor
assay
g
opposit
u
primertempl
symsubu
polymeras
assembl
absenc
nucleotid
gtp
excess
unlabel
trap
rna
ad
incub
period
excess
rna
trap
ensur
polymeras
dissoci
primertempl
taken
trap
reassembl
b
kpol
kd
gmp
misincorpor
concentr
gtp
use
timepoint
calcul
kpol
kd
gtp
timecours
plot
singl
exponenti
combin
plot
hyperbola
note
polymeras
variant
mutat
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
figur
log
fit
versu
passag
adapt
experi
point
fit
mean
standard
deviat
three
replic
competit
assay
wt
hela
b
wt
graph
b
relationship
log
fit
vs
passag
linear
past
passag
passag
shown
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
figur
mutagen
sensit
variant
hela
infect
moi
indic
virus
presenc
variou
concentr
ribavirin
hour
titer
mock
ribavirintr
popul
determin
ribavirintr
popul
normal
mocktreat
control
mean
measur
per
viru
shown
chang
titer
yaxi
mean
replic
viru
drug
concentr
xaxi
greater
reduct
titer
neg
number
indic
higher
mutagen
sensit
suggest
higher
baselin
mutat
rate
